Abstract
Purpose. To evaluate the effectiveness of treatment of ophthalmic hypertension in patients after vitreoretinal surgery with various tamponade of the vitreal cavity. Material and methods. 344 case histories of patients aged 30 to 80 years who underwent vitreoretinal intervention for macular rupture, epiretinal membrane, hemophthalmos, retinal detachment with various tamponade of the vitreal cavity in the period from 2019 to 2021 were analyzed. To detect ophthalmohypertension, all the studied patients underwent tonometry before surgery and every month after during the entire follow-up period. The observation period was 2 years. Results. Of the 46 patients who were diagnosed with ophthalmohypertension after vitreoretinal surgery, 18 patients had intraocular pressure compensation during 2 years of follow-up, they did not require hypotensive therapy. 28 patients were prescribed hypotensive therapy (carbonic anhydrase inhibitors, α2-adrenomimetics), of which 4 patients had glaucoma before vitreoretinal intervention. 2 patients were implanted with an Express anti-glaucomatous device. Conclusion. The analysis of the effectiveness of treatment of ophthalmic hypertension in patients after vitreoretinal surgery showed that compensation of intraocular pressure occurs differently in each case, an individual approach is needed. One antihypertensive drug is not always enough, in some cases it is necessary to strengthen antihypertensive therapy, and sometimes anti-glaucoma surgical interventions. Keywords: vitreoretinal surgery, ophthalmohypertension, secondary glaucoma.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
